Methylation status of NEUROG2 and NID2 improves the diagnosis of stage I NSCLC

Author：

ISSN： 1792-1074

Source： Oncology Letters, Vol.3, Iss.4, 2012-01, pp. : 901-906

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Promoter methylation status of the FHIT gene and Fhit expression: Association with HER2/neu status in breast cancer patients

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2270-2278

Spandidos Publications

Access to resources Recommend Favorite

Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study

By Kreuter M. Vansteenkiste J. Fischer J. R. Eberhardt W. Zabeck H. Kollmeier J. Serke M. Frickhofen N. Reck M. Engel-Riedel W. Neumann S. Thomeer M. Schumann C. De Leyn P. Graeter T. Stamatis G. Zuna I. Griesinger F. Thomas M.

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 986-992

Oxford University Press

Access to resources Recommend Favorite

Effect of HER2 status on distant recurrence in early stage breast cancer

By Hess Kenneth

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 449-455

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy and quality of life in NSCLC PS 2 patients

By Helbekkmo Nina Strøm Hans Sundstrøm Stein Aasebø Ulf Von Plessen Christian Bremnes Roy

Acta Oncologica, Vol. 48, Iss. 7, 2009-10 ,pp. : 1019-1025

Informa Healthcare

Access to resources Recommend Favorite

Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates

International Journal of Oncology, Vol. 40, Iss. 3, 2012-01 ,pp. : 825-832

Spandidos Publications

Access to resources Recommend Favorite